Genomic screening is transforming prenatal and neonatal care, offering new insights and challenges in equal measure. Our latest report, "Precision from the start: Balancing progress and principles in prenatal and neonatal care," dives into these advancements and the ethical dilemmas they present.
Since decoding the first human genome, innovations like gene panel testing and non-invasive prenatal testing (NIPT) have brought us closer to personalised medicine from birth. These technologies not only enhance our understanding of genetic conditions but also raise significant ethical concerns around privacy and informed consent as well as issues of access and equity. This report emphasises the importance of integrating genetic data into pre- and neonatal care while navigating ethical considerations with sensitivity.
"Precision from the start" offers a look at the current state of prenatal and neonatal genomic screening and its potential to transform healthcare. For an in-depth exploration of these issues and more, download the report below.
